Emergent BioSolutions tumbles 7% after J&J says it spoiled 15 million COVID-19 vaccine doses (EBS, JNJ, AZN)Business Insider • 04/01/21
Why Is Emergent Biosolutions (EBS) Down 22.3% Since Last Earnings Report?Zacks Investment Research • 03/20/21
New York Times Credits Report On Emergent BioSolutions For Biden's Canceled Vaccine Plant VisitBenzinga • 03/09/21
Abercrombie, Mattel, Western Digital and More Wednesday Afternoon Analyst Calls24/7 Wall Street • 02/24/21
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/19/21
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020GlobeNewsWire • 02/18/21
Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021GlobeNewsWire • 02/04/21
Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drugMarket Watch • 01/25/21
Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™Business Wire • 01/25/21
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 ResultsGlobeNewsWire • 01/10/21
3 Reasons Why Growth Investors Shouldn't Overlook Emergent Biosolutions (EBS)Zacks Investment Research • 01/07/21
Emergent Biosolutions (EBS) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 01/06/21